Mortality benefits and overdiagnosis estimates for women attending breast screening
- PMID: 23744279
- PMCID: PMC3681022
- DOI: 10.1038/bjc.2013.260
Mortality benefits and overdiagnosis estimates for women attending breast screening
Comment on
-
The benefits and harms of breast cancer screening: an independent review.Br J Cancer. 2013 Jun 11;108(11):2205-40. doi: 10.1038/bjc.2013.177. Epub 2013 Jun 6. Br J Cancer. 2013. PMID: 23744281 Free PMC article. Review. No abstract available.
References
-
- Cancer Research UK 2012Breast Screening ReviewAvailable at www.cruk.org/breastscreeningreview (accessed May 2013).
-
- Collette HJA, Rombach JJ, Day NE, de Waard F. Evaluation of screening for breast cancer in a non-randomised study (The DOM Project) by means of a case-control study. Lancet. 1984;1 (8388:1224–1226. - PubMed
-
- Independent UK Panel on Breast Cancer Screening 2012The benefits and harms of breast cancer screening: an independent review Lancet 380(9855):1778–1786. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical